[HTML][HTML] Avoidance of β-blockers in patients who use stimulants is not supported by good evidence
T Wilson, I Pitcher, P Bach - CMAJ, 2022 - Can Med Assoc
• Patients who use stimulants such as crystal methamphetamine and cocaine often have
cardiovascular conditions for which β-blockers are part of the standard of care.• Many …
cardiovascular conditions for which β-blockers are part of the standard of care.• Many …
Beta blockers and the cardiac complications of methamphetamine
JR Richards - Heart, Lung and Circulation, 2017 - heartlungcirc.org
I enjoyed reading the excellent review on the cardiac complications of methamphetamine by
Drs. Paratz, Cunningham, and MacIsaac [1]. However I must comment on their treatment …
Drs. Paratz, Cunningham, and MacIsaac [1]. However I must comment on their treatment …
Response to 'Beta-Blockers and The Cardiac Complications of Methamphetamines'
ED Paratz, N Cunningham… - Heart, Lung and …, 2017 - heartlungcirc.org
We thank Dr Richards [1] for his expert comments on our review [2]. Dr Richards points out
that unfortunately there is a dearth of high-quality evidence guiding the administration of …
that unfortunately there is a dearth of high-quality evidence guiding the administration of …
Trends in off-label β-blocker use: A secondary data analysis
HW Lin, K Phan, SJ Lin - Clinical therapeutics, 2006 - Elsevier
BACKGROUND:: The off-label use of β-blockers might be prevalent, but no studies have
provided empiric data on the off-label use based on utilization data. OBJECTIVE:: This …
provided empiric data on the off-label use based on utilization data. OBJECTIVE:: This …
[HTML][HTML] Major side effects of beta blockers
PJ Podrid - UpToDate. Waltham (MA): UpToDate. Available at …, 2020 - medilib.ir
INTRODUCTION—Most of the major adverse effects of beta blocking drugs result from beta-
adrenoreceptor blockade. Many signs and symptoms can therefore be induced because the …
adrenoreceptor blockade. Many signs and symptoms can therefore be induced because the …
β-Blockers: Drug interactions of clinical significance
I Blaufarb, TM Pfeifer, WH Frishman - Drug Safety, 1995 - Springer
The clinician prescribing β-blockers for his or her patients is faced with an often difficult
situation. There are many β-blockers, each with its own pharmacological profile. Patients are …
situation. There are many β-blockers, each with its own pharmacological profile. Patients are …
Misconceptions and facts about beta-blockers
E Argulian, S Bangalore, FH Messerli - The American journal of medicine, 2019 - Elsevier
Beta-blockers are commonly used medications, and they have been traditionally considered
“cardioprotective.” Their clinical use appears to be more widespread than the available …
“cardioprotective.” Their clinical use appears to be more widespread than the available …
Impact of clinical trial results on national trends in α-blocker prescribing, 1996-2002
RS Stafford, CD Furberg, SN Finkelstein, IM Cockburn… - Jama, 2004 - jamanetwork.com
ContextResearch on factors that influence prescribing patterns and the extent of change
produced by clinical trial findings is limited. ObjectiveTo examine the changes in prescribing …
produced by clinical trial findings is limited. ObjectiveTo examine the changes in prescribing …
Beta-blockers and adverse effects: dispelling the myths.(Drug Spotlight).
PC Deedwania - Patient Care, 2002 - go.gale.com
Beta-blockers are underutilized in many patients. Barriers include perceived and real
contraindications and frequently cited adverse effects. Misperceptions abound about the …
contraindications and frequently cited adverse effects. Misperceptions abound about the …
Beta-blockers: off-label use in psychiatric disorders
WJ Newman, GL Xiong, AV Barnhorst - Psychopharm Review, 2013 - journals.lww.com
The authors have disclosed that the use of beta-beta blockers such as propranolol, pindolol,
atenolol, and metoprolol for psychiatric disorders as discussed in this article has not been …
atenolol, and metoprolol for psychiatric disorders as discussed in this article has not been …